Become A Featured Company

The Best Little Pot Farm In Europe

Marguerite Arnold

January 29th, 2018

Policy

Forget cannabis reform in California. The dawn of the state recreational market is clearly going to change the discussion in the U.S. in ways that so far, other state reform has yet to broach.

And also skip over any conversations about what is happening north of the border. Canadians are going to pioneer national recreational cultivation and distribution in a way and at a level unseen, or unregulated, anywhere else.

But don’t count Europe out yet. For all the kvetching about delays, complications, regulations and EU politics in general, there are clearly budding cannabis crops all over the continent – and in places that might just surprise you.

Sure, they might not be as commercial and buzzy as their North American counterparts. However things are moving at a pace in at least four countries right now on the medical side that well may upend the entire discussion in Europe in 2018 – and on several important fronts.

Even more interestingly, such green patches of progress are in strategic areas that will definitely move the entire legalization conversation forward not only in Europe but other places.

There is Something Dank Going Down in Denmark

Nobody is quite sure how this happened. But quietly, as of Q’4 2017, the tiny Euro country of Denmark managed to attract the investment dollars of not one but two major Canadian cannabis firms. Both Spektrum/Canopy Cannabis and Aurora have announced grow facilities in the country.

Even more astoundingly, the Danish government has quietly allowed Danish farmers to begin growing the plant for medical use in 2018. This is the first year of a four year experiment to see how medical cannabis works across the country, and funded to the tune of 22 million kroner.

That said, medical resistance to the initiative is still very high domestically. Doctors are resisting prescribing the drug as the trial gets underway.

Local development, however, appears to being going gangbusters. Close to 100 million euros in funding has already been invested in Danish production facilities by foreign firms of late as well as local investment. What does not get used domestically can also be shipped across borders – including into a German market which is undoubtedly potentially larger – and so far has yet to kick off its own domestic grow program.

The Italian Army Appears To Be Loosening Its Military Monopoly on Marijuana

One of the stranger approaches to legalization if not liberalization has been going on in Italy for some years. Up until now, the Italian military had taken the lead if not the sole rights, to grow medical marijuana in the country. Given the country’s Mediterranean coastline, proximity to Turkey and history with drug smuggling done by the real Mafia et al, this was perhaps an understandable wobble. However, in breaking news out of Europe, it appears that Aurora has snagged the exclusive and first Italian government medical cannabis tender. Who knows where that will go? However, with the first cannabis café now opened in Rome, this is the sort of development that is going to send (at minimum) every other foreign LP and distributor looking for new opportunities across the EU. And that, by definition is going to lead to more EU based medical cultivation, processing and distribution activity. By definition.

If that does not now also move the Germans, what will? Medical marijuana is one of the few things that the still-squabbling parties in the midst of forming a new government can actually agree on.

Greek’s Great Green Bailout Program?

The Danish and Italian experimentation with cannabis (not to mention what is already afoot in Germany, Spain, Portugal and Eastern Europe), however, pales in comparison to what the Greeks are planning on the medical front. While everyone else might be bowing to the inevitable, what is about to begin happening in Greece is likely to reset the scales of the canna-biz in Europe on every front. If not jump-start the conversation.

Why? The first thing is that the government is set to finally set sail beyond the financing of its foreign debtors this year after a final passage of labour reforms.

What the government is also doing, however, is opening a global bid for foreign cannabis capital to consider relocation if not cultivation of medical cannabis domestically. The government is hoping to attract at least USD$2 billion in foreign capital interested in a vibrant and again-booming tourist industry that broke records last summer – for the second summer in a row.

If things continue to develop as they appear to be so far, look for a vibrant, lucrative, medical cannabis industry in Greece sooner rather than later, that also caters to tourists.

Medical cannabis travel visas anyone?

For this reason, the development of a Greek medical cannabis industry is potentially as transformative to the entire medical/recreational discussion as the reciprocal visas initiated by Nevada. On a continental scale. Remember that insurance coverage “travels” here far easier than anywhere else internationally.

It may well also tip the entire discussion across the continent about real reform.

Locally, at least, this is also going to create lucrative cannabrands if not opportunities that could also well be exported – even if “only” to help continue to boost the Greek economy.

Unlike the U.S., of course, there will be no Jeff Sessions to slow down industry development. In fact, precisely the opposite. In fact, in Greece, the scales might finally be turned on the institutional investment front when it comes to cannabis in a way unseen anywhere else in the world to date.

And that conversation might well, then, finally and fundamentally tip the scales everywhere else.

Doesn’t that make you want to get your medical card, not to mention your investment fund stamped “Greece or Bust?”

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Marguerite Arnold

Marguerite Arnold is a veteran investigative and markets journalist, American expat and author. She has covered the cannabis industry from Germany for the last six years. Her book, Green: The First Year of Modern American Cannabis Reform about the American market in 2014 has just been republished as she is writing the sequel about Europe and the global revolution this year. Green II: Spreading Like Kudzu will be published in 2020. She is also a noted technologist and entrepreneur. Her blockchain-based digital prescription platform MedPayRx was just shortlisted by the German Ministry of Health as one of the "Top 20" use cases for blockchain in healthcare.

Network Partners

Follow Us on Social Media

LinkedIn

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading